High sensitivity cardiac troponin T in patients with immunoglobulin light chain amyloidosis

Cardiac Troponin T Measured by a Highly Sensitive Assay Predicts Coronary Heart Disease, Heart Failure, and Mortality in the Atherosclerosis Risk in Communities Study

(2011) Justin T. Saunders et al.   CIRCULATION

Multicenter analytical evaluation of a high-sensitivity troponin T assay

(2011) A.K. Saenger et al.   CLINICA CHIMICA ACTA

Utility of Doppler Myocardial Imaging, Cardiac Biomarkers, and Clonal Immunoglobulin Genes to Assess Left Ventricular Performance and Stratify Risk Following Peripheral Blood Stem Cell Transplantation in Patients with Systemic Light Chain Amyloidosis (AL)

(2011) Diego Bellavia et al.   JOURNAL OF THE AMERICAN SOCIETY OF ECHOCARDIOGRAPHY

Discordance between serum cardiac biomarker and immunoglobulin-free light-chain response in patients with immunoglobulin light-chain amyloidosis treated with immune modulatory drugs

(2010) Angela Dispenzieri et al.   AMERICAN JOURNAL OF HEMATOLOGY

Assessment of disease severity and outcome in patients with systemic light-chain amyloidosis by the high-sensitivity troponin T assay

(2010) A. V. Kristen et al.   BLOOD

The combination of high-sensitivity cardiac troponin T (hs-cTnT) at presentation and changes in N-terminal natriuretic peptide type B (NT-proBNP) after chemotherapy best predicts survival in AL amyloidosis

(2010) G. Palladini et al.   BLOOD

Sensitive and high sensitivity cardiac troponin I concentrations in the Heart Outcomes Prevention Evaluation (HOPE) study — A high risk population

(2010) Peter A. Kavsak et al.   CLINICA CHIMICA ACTA

Association of Troponin T Detected With a Highly Sensitive Assay and Cardiac Structure and Mortality Risk in the General Population

(2010) James A. de Lemos et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Bortezomib With or Without Dexamethasone in Primary Systemic (Light Chain) Amyloidosis

(2010) Efstathios Kastritis et al.   JOURNAL OF CLINICAL ONCOLOGY

Autologous stem cell transplant for immunoglobulin light chain amyloidosis: a status report

(2010) Morie A. Gertz et al.   LEUKEMIA & LYMPHOMA

Recent Improvements in Survival in Primary Systemic Amyloidosis and the Importance of an Early Mortality Risk Score

(2010) Shaji K. Kumar et al.   MAYO CLINIC PROCEEDINGS

Analytic and Clinical Utility of a Next-Generation, Highly Sensitive Cardiac Troponin I Assay for Early Detection of Myocardial Injury

(2009) P. A. Kavsak et al.   CLINICAL CHEMISTRY

Analytical Validation of a High-Sensitivity Cardiac Troponin T Assay

(2009) E. Giannitsis et al.   CLINICAL CHEMISTRY

Normal Plasma Levels of Cardiac Troponin I Measured by the High-Sensitivity Cardiac Troponin I Access Prototype Assay and the Impact on the Diagnosis of Myocardial Ischemia

(2009) Per Venge et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

A Sensitive Cardiac Troponin T Assay in Stable Coronary Artery Disease

(2009) Torbjørn Omland et al.   NEW ENGLAND JOURNAL OF MEDICINE

Diagnostic and Prognostic Utility of Cardiovascular Magnetic Resonance Imaging in Light-Chain Cardiac Amyloidosis

(2008) Frederick L. Ruberg et al.   AMERICAN JOURNAL OF CARDIOLOGY

Predictors of survival in patients with systemic light-chain amyloidosis and cardiac involvement initially ineligible for stem cell transplantation and treated with oral melphalan and dexamethasone

(2008) D. Lebovic et al.   BRITISH JOURNAL OF HAEMATOLOGY

Troponin T level as an exclusion criterion for stem cell transplantation in light-chain amyloidosis

(2008) Morie Gertz et al.   LEUKEMIA & LYMPHOMA